JESSE MCCLELLAND: Open Payments
NPI 1033395587 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 9 payments from 4 companies in 2025. Trend: 2023 $222 · 2024 $8,222 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 4 | $85 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Dyanavel XR, Qelbree, CAPLYTA, Ozempic.
Industry payments across WA — which companies pay providers there.
